Safety profile of MLC601 (Neuroaid®) in acute ischemic stroke patients: A Singaporean substudy of the chinese medicine neuroaid efficacy on stroke recovery study
10.1159/000313398
Saved in:
Main Authors: | Young, S.H.Y., Zhao, Y., Koh, A., Singh, R., Chan, B.P.L., Venketasubramanian, N., Chen, C., Chang, H.M. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/27252 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
NeuroAid II (MLC901) in Haemorrhagic Stroke
by: Chai-Hoon Nowel Tan, et al.
Published: (2021) -
A double-blind, placebo-controlled, randomized phase II pilot study to investigate the potential efficacy of the traditional Chinese medicine neuroaid (MLC 601) in enhancing recovery after stroke (TIERS)
by: Kong, K.H., et al.
Published: (2016) -
Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study
by: Venketasubramanian, Narayanaswamy, et al.
Published: (2021) -
Prognostic factors and pattern of long-term recovery with MLC601 (NeuroAiD™) in the Chinese medicine NeuroAiD efficacy on stroke recovery - Extension study
by: Venketasubramanian, N, et al.
Published: (2020) -
Efficacy and safety of MLC601 (NeuroAiD®), a traditional chinese medicine, in poststroke recovery: A systematic review
by: Siddiqui, F.J., et al.
Published: (2014)